215 related articles for article (PubMed ID: 16029970)
1. Drug-related thrombosis in hematologic malignancies.
Nadir Y; Hoffman R; Brenner B
Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects on hemostatic function of drugs used in hematologic malignancies.
Zakarija A; Kwaan HC
Semin Thromb Hemost; 2007 Jun; 33(4):355-64. PubMed ID: 17525893
[TBL] [Abstract][Full Text] [Related]
3. Hematologic malignancies and thrombosis.
Elice F; Rodeghiero F
Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis in children with hematologic malignancies.
Schobess R; Kempf-Bielack B; Schwabe D; Sträter R; Nowak-Göttl U
Rev Clin Exp Hematol; 2004 Jun; 8(1):E2. PubMed ID: 16029968
[TBL] [Abstract][Full Text] [Related]
5. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
Tallman MS; Kwaan HC
Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
[TBL] [Abstract][Full Text] [Related]
6. Thrombosis and hemostatic abnormalities in hematological malignancies.
Colombo R; Gallipoli P; Castelli R
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):441-50. PubMed ID: 25018062
[TBL] [Abstract][Full Text] [Related]
7. Management of thrombosis in patients with hematologic malignancies.
Piccioli A; Vianello F; Prandoni P
Curr Hematol Rep; 2002 Sep; 1(1):79-83. PubMed ID: 12901128
[TBL] [Abstract][Full Text] [Related]
8. The thrombophilic state induced by therapeutic agents in the cancer patient.
Lee AY; Levine MN
Semin Thromb Hemost; 1999; 25(2):137-45. PubMed ID: 10357081
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic Risk from Chemotherapy and Other Cancer Therapies.
Debbie Jiang MD; Alfred Ian Lee MD
Cancer Treat Res; 2019; 179():87-101. PubMed ID: 31317482
[TBL] [Abstract][Full Text] [Related]
10. Management of thromboembolism in hematologic malignancies.
Chong BH; Lee SH
Semin Thromb Hemost; 2007 Jun; 33(4):435-48. PubMed ID: 17525901
[TBL] [Abstract][Full Text] [Related]
11. Prevention of thrombosis in ambulatory patients with cancer.
Rana P; Levine MN
J Clin Oncol; 2009 Oct; 27(29):4885-8. PubMed ID: 19752331
[TBL] [Abstract][Full Text] [Related]
12. Assessment of hemostatic risk factors in predicting arterial thrombotic events.
Feinbloom D; Bauer KA
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2043-53. PubMed ID: 16100033
[TBL] [Abstract][Full Text] [Related]
13. [Thrombosis and DIC in hematological malignancies].
Asakura H
Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
[No Abstract] [Full Text] [Related]
14. Thromboembolism in cancer patients: pathogenesis and treatment.
Adess M; Eisner R; Nand S; Godwin J; Messmore HL; Wehrmacher WH
Clin Appl Thromb Hemost; 2006 Jul; 12(3):254-66. PubMed ID: 16959679
[TBL] [Abstract][Full Text] [Related]
15. Use of anti-thrombotic agents during chemotherapy for epithelial ovarian cancer.
Salman MC; Ayhan A
Med Hypotheses; 2006; 66(6):1179-81. PubMed ID: 16446052
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology of chemotherapy-associated thrombosis].
Lechner D; Weltermann A
Hamostaseologie; 2009 Jan; 29(1):112-20. PubMed ID: 19151860
[TBL] [Abstract][Full Text] [Related]
17. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Timely Top Med Cardiovasc Dis; 2006 Aug; 10():E19. PubMed ID: 17066136
[TBL] [Abstract][Full Text] [Related]
18. Thromboprophylaxis during chemotherapy after advanced cancer.
Agnelli G; Verso M
Thromb Res; 2007; 120 Suppl 2():S128-32. PubMed ID: 18023706
[TBL] [Abstract][Full Text] [Related]
19. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.
Hussein MA
Thromb Haemost; 2006 Jun; 95(6):924-30. PubMed ID: 16732369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
